HUMAN IMMUNE RESPONSE TO HEPATITIS B VACCINE

乙型肝炎疫苗的人体免疫反应

基本信息

  • 批准号:
    6241773
  • 负责人:
  • 金额:
    $ 41.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-03-01 至 1998-02-28
  • 项目状态:
    已结题

项目摘要

The objective of this project is to understand the genetic basis and mechanisms of the immune response and of the failure of response to the major surface antigen of the hepatitis B virus, HBsAg. The extent to which the response is genetically controlled will be defined by immunizing identical twins and their immediate family members and comparing their response with that of MHC-identical siblings. From the study of these and other families and from studies of the response in vitro, the major T cell epitopes of HBsAg will be defined and the response or nonresponse will be correlated with specific major histocompatibility complex (MHC) alleles and fixed, extended haplotypes. The binding of an immunodominant nonapeptide epitope and other T cell epitopes to dendritic cells, monocytes, and B lymphocytes and to isolated class II molecules will be examined and binding will be correlated with the presence or absence of immune response. From the careful study, including sequence determinations in class II genes, of rare responding individuals who are homozygotes for usually nonresponding extended haplotypes or who are MHC identical sibs of nonresponders, we hope to determine whether nucleotide changes affecting the peptide-binding cleft or other parts of class II molecules occur with some frequency and result in response. The relationship between T cell antigen receptor (TCR) Alpha and Vbeta gene and sequence usage and specific MHC alleles and extended haplotypes will be defined in responders and nonresponders to HBsAg. TCR V genes and sequences on T cells proliferating in response to whole HBsAG as well as to individual epitopes will be compared with the overall repertoire of the same responders before boosting and of nonresponders. The results of these studies will be compared with those of Project 2 which explore whether the defect in nonresponders is in antigen presentation or T cell recognition. The effects of possible sequence changes in MHC class II molecules and susceptibility to IgA and other immunoglobulin deficiency (Project 3) will also be examined.
这个项目的目的是了解遗传基础和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHESTER Allan ALPER其他文献

CHESTER Allan ALPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHESTER Allan ALPER', 18)}}的其他基金

GENETICS OF IGA AND OTHER IMMUNOGLOBULIN DEFICIENCIES
IGA 和其他免疫球蛋白缺陷的遗传学
  • 批准号:
    6829682
  • 财政年份:
    2003
  • 资助金额:
    $ 41.64万
  • 项目类别:
HUMAN IMMUNE RESPONSE TO HEPATITIS B VACCINE
乙型肝炎疫苗的人体免疫反应
  • 批准号:
    6829680
  • 财政年份:
    2003
  • 资助金额:
    $ 41.64万
  • 项目类别:
CORE A- ADMINISTRATIVE CORE
核心 A- 行政核心
  • 批准号:
    6988263
  • 财政年份:
    2003
  • 资助金额:
    $ 41.64万
  • 项目类别:
IMMUNOPATHOGENETIC MECHANISMS OF SELECTIVE IGA DEFICIENCY
选择性 IGA 缺陷的免疫致病机制
  • 批准号:
    6109677
  • 财政年份:
    1999
  • 资助金额:
    $ 41.64万
  • 项目类别:
HUMAN IMMUNE RESPONSE TO HEPATITIS B VACCINE
乙型肝炎疫苗的人体免疫反应
  • 批准号:
    6109675
  • 财政年份:
    1999
  • 资助金额:
    $ 41.64万
  • 项目类别:
IMMUNOPATHOGENETIC MECHANISMS OF SELECTIVE IGA DEFICIENCY
选择性 IGA 缺陷的免疫致病机制
  • 批准号:
    6272669
  • 财政年份:
    1998
  • 资助金额:
    $ 41.64万
  • 项目类别:
HUMAN IMMUNE RESPONSE TO HEPATITIS B VACCINE
乙型肝炎疫苗的人体免疫反应
  • 批准号:
    6272667
  • 财政年份:
    1998
  • 资助金额:
    $ 41.64万
  • 项目类别:
IMMUNOPATHOGENETIC MECHANISMS OF SELECTIVE IGA DEFICIENCY
选择性 IGA 缺陷的免疫致病机制
  • 批准号:
    6241775
  • 财政年份:
    1997
  • 资助金额:
    $ 41.64万
  • 项目类别:
NONREPONSE TO THE HEPATITIS B VACCINE
对乙型肝炎疫苗无反应
  • 批准号:
    2071431
  • 财政年份:
    1995
  • 资助金额:
    $ 41.64万
  • 项目类别:
NONREPONSE TO THE HEPATITIS B VACCINE
对乙型肝炎疫苗无反应
  • 批准号:
    2457783
  • 财政年份:
    1995
  • 资助金额:
    $ 41.64万
  • 项目类别:

相似海外基金

FAMILY GENETICS OF AUTISM AND ASPERGER DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6505593
  • 财政年份:
    2001
  • 资助金额:
    $ 41.64万
  • 项目类别:
FAMILY GENETICS OF AUTISM AND ASPERGER DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6480457
  • 财政年份:
    2001
  • 资助金额:
    $ 41.64万
  • 项目类别:
FAMILY GENETICS OF AUTISM AND ASPERGER DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6359630
  • 财政年份:
    2000
  • 资助金额:
    $ 41.64万
  • 项目类别:
FAMILY GENETICS OF AUTISM AND ASPERGER DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6336606
  • 财政年份:
    2000
  • 资助金额:
    $ 41.64万
  • 项目类别:
FAMILY GENETICS OF AUTISM AND ASPERGER DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6202109
  • 财政年份:
    1999
  • 资助金额:
    $ 41.64万
  • 项目类别:
FAMILY GENETICS OF AUTISM AND ASPERGER DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6108895
  • 财政年份:
    1998
  • 资助金额:
    $ 41.64万
  • 项目类别:
FAMILY GENETICS OF AUTISM AND ASPERGER'S DISORDER
自闭症和阿斯伯格症的家族遗传学
  • 批准号:
    6241397
  • 财政年份:
    1997
  • 资助金额:
    $ 41.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了